| PERIOD ENDING | 30-Sep-08 | | Total Revenue | 35,437 | | Cost of Revenue | 14,630 | | | Gross Profit | 20,807 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 12,642 | | Non Recurring |
-
| | Others | 1,609 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 6,557 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| | Earnings Before Interest And Taxes | 6,557 | | Interest Expense | 4,475 | | Income Before Tax | 2,082 | | Income Tax Expense | 630 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 1,452 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 1,452 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $1,452 |
|
0.63% Nasdaq 
0.03%
Income Statement
